DE60237089D1 - Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren - Google Patents

Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren

Info

Publication number
DE60237089D1
DE60237089D1 DE60237089T DE60237089T DE60237089D1 DE 60237089 D1 DE60237089 D1 DE 60237089D1 DE 60237089 T DE60237089 T DE 60237089T DE 60237089 T DE60237089 T DE 60237089T DE 60237089 D1 DE60237089 D1 DE 60237089D1
Authority
DE
Germany
Prior art keywords
sup
sub
alkyl
hcv polymerase
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60237089T
Other languages
English (en)
Inventor
George Kukolj
Pierre L Beaulieu
Ginette Mckercher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Application granted granted Critical
Publication of DE60237089D1 publication Critical patent/DE60237089D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/91245Nucleotidyltransferases (2.7.7)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60237089T 2001-08-07 2002-08-05 Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren Expired - Lifetime DE60237089D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31027201P 2001-08-07 2001-08-07
PCT/CA2002/001214 WO2003014377A2 (en) 2001-08-07 2002-08-05 Competitive binding assay for identifying inhibitors of hcv polymerase

Publications (1)

Publication Number Publication Date
DE60237089D1 true DE60237089D1 (de) 2010-09-02

Family

ID=23201740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60237089T Expired - Lifetime DE60237089D1 (de) 2001-08-07 2002-08-05 Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren

Country Status (13)

Country Link
US (1) US7294457B2 (de)
EP (1) EP1417493B1 (de)
JP (1) JP4646514B2 (de)
AT (1) ATE475095T1 (de)
CA (1) CA2450142C (de)
DE (1) DE60237089D1 (de)
DK (1) DK1417493T3 (de)
ES (1) ES2347954T3 (de)
HU (1) HUP0400670A3 (de)
IL (1) IL159981A0 (de)
MX (1) MXPA04001127A (de)
NZ (2) NZ554933A (de)
WO (1) WO2003014377A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (de) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) * 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7592352B2 (en) 2003-05-06 2009-09-22 Smithkline Beecham Corporation Substituted thieno and furo-pyridines
US7511145B2 (en) 2003-08-01 2009-03-31 Genelabs Technologies, Inc. Bicyclic heteroaryl derivatives
USRE47600E1 (en) 2003-11-10 2019-09-10 STATS ChipPAC Pte. Ltd. Semiconductor device and method of forming electrical interconnect with stress relief void
US8216930B2 (en) 2006-12-14 2012-07-10 Stats Chippac, Ltd. Solder joint flip chip interconnection having relief structure
WO2005048311A2 (en) 2003-11-10 2005-05-26 Chippac, Inc. Bump-on-lead flip chip interconnection
US8574959B2 (en) 2003-11-10 2013-11-05 Stats Chippac, Ltd. Semiconductor device and method of forming bump-on-lead interconnection
US9029196B2 (en) 2003-11-10 2015-05-12 Stats Chippac, Ltd. Semiconductor device and method of self-confinement of conductive bump material during reflow without solder mask
US8026128B2 (en) 2004-11-10 2011-09-27 Stats Chippac, Ltd. Semiconductor device and method of self-confinement of conductive bump material during reflow without solder mask
US8129841B2 (en) 2006-12-14 2012-03-06 Stats Chippac, Ltd. Solder joint flip chip interconnection
EP1688420A4 (de) * 2003-11-19 2008-10-22 Japan Tobacco Inc 5-5-gliedrige kondensierte heterocyclische verbindung und deren verwendung als hcv-polymeraseinhibitor
PL1706403T3 (pl) * 2003-12-22 2012-07-31 K U Leuven Res & Development Związki imidazo[4,5-c]pirydynowe i sposoby leczenia przeciwwirusowego
KR20120091276A (ko) * 2004-02-20 2012-08-17 베링거 인겔하임 인터내셔날 게엠베하 바이러스 폴리머라제 억제제
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
ATE428714T1 (de) * 2004-02-24 2009-05-15 Japan Tobacco Inc Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor
BRPI0511834A (pt) * 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c
DE602005013580D1 (de) * 2004-12-21 2009-05-07 Leuven K U Res & Dev Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung
US8703795B2 (en) 2005-03-02 2014-04-22 Fibrogen, Inc. Thienopyridine compounds, and methods of use thereof
JP2008535225A (ja) 2005-03-25 2008-08-28 スタッツ チップパック リミテッド 基板上に狭い配線部分を有するフリップチップ配線
US8841779B2 (en) 2005-03-25 2014-09-23 Stats Chippac, Ltd. Semiconductor device and method of forming high routing density BOL BONL and BONP interconnect sites on substrate
CA2618682C (en) * 2005-08-12 2011-06-21 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP2044028B1 (de) 2006-01-27 2012-05-16 Fibrogen, Inc. Cyanoisochinoline zur stabilisierung des hypoxie-induzierten faktors (hif)
WO2007115315A2 (en) * 2006-04-04 2007-10-11 Fibrogen, Inc. Pyrrolo- and thiazolo-pyridine compounds as hif modulators
TWI360549B (en) * 2006-07-07 2012-03-21 Gilead Sciences Inc Novel pyridazine compound and use thereof
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
WO2010056767A1 (en) 2008-11-14 2010-05-20 Fibrogen, Inc. Thiochromene derivatives as hip hydroxylase inhibitors
RU2015114772A (ru) 2012-09-21 2016-11-10 Санофи Производные амида бензоимидазол-карбоновой кислоты в качестве модуляторов рецептора apj
AU2014209319B2 (en) 2013-01-24 2018-04-19 Fibrogen, Inc. Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
CR20180413A (es) 2016-02-05 2018-12-04 Denali Therapeutics Inc Inhibidores de la proteína quinasa 1 que interactua con el receptor
WO2018107060A1 (en) 2016-12-09 2018-06-14 Denali Therapeutics Inc. Compounds, compositions and methods
TW202334089A (zh) 2021-11-02 2023-09-01 美商夫雷爾醫療公司 Pparg反向激動劑及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2334161A1 (en) * 1998-07-20 2000-01-27 Ribozyme Pharmaceuticals, Inc. Use of nucleic acid molecules as antiviral agents
JP2001069995A (ja) * 1999-07-02 2001-03-21 Japan Tobacco Inc 結晶構造解析に適したhcvポリメラーゼ及びその利用方法
US6770666B2 (en) * 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
CA2363274A1 (en) 1999-12-27 2001-07-05 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs for hepatitis c
US6448281B1 (en) * 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
JP2004520839A (ja) 2001-03-08 2004-07-15 ベーリンガー インゲルハイム (カナダ) リミテッド Hcvのrna依存性rnaポリメラーゼ(ns5b)の阻害剤を同定するための分析法
WO2003007945A1 (en) 2001-07-20 2003-01-30 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (de) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur

Also Published As

Publication number Publication date
NZ554933A (en) 2009-01-31
HUP0400670A3 (en) 2006-06-28
IL159981A0 (en) 2004-06-20
JP2005500055A (ja) 2005-01-06
EP1417493B1 (de) 2010-07-21
US20030108862A1 (en) 2003-06-12
ATE475095T1 (de) 2010-08-15
ES2347954T3 (es) 2010-11-26
DK1417493T3 (da) 2010-10-04
NZ531488A (en) 2008-06-30
WO2003014377A2 (en) 2003-02-20
MXPA04001127A (es) 2004-07-08
US7294457B2 (en) 2007-11-13
CA2450142A1 (en) 2003-02-20
EP1417493A2 (de) 2004-05-12
CA2450142C (en) 2009-12-22
HUP0400670A2 (en) 2006-03-28
WO2003014377A3 (en) 2003-12-18
JP4646514B2 (ja) 2011-03-09

Similar Documents

Publication Publication Date Title
DE60237089D1 (de) Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren
DE60334524D1 (de) E2-verdrängungs-assay zur identifizierung von hpv-inhibitoren
DK1414797T3 (da) Hepatitis C-viruspolymeraseinhibitorer med en heterobicyklisk struktur
ATE556323T1 (de) Neurofibrilläre marker
TNSN04163A1 (fr) N-aryl-2-oxazolidinone-5-carboxamides et leurs derives et leur utilisation comme agents antibacteriens
DE602005023529D1 (de) Homogener nachweis von analyten
WO2006128138A3 (en) Biodetection by nucleic acid-templated chemistry
DE60020584D1 (de) Verbindungen zur floureszenz-kennzeichnung
ATE342896T1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
ATE437965T1 (de) Doppelsträngige sonden zur fluoreszenzdetektion von nukleinsäuren
DE50209786D1 (de) 7-aminotriazolopyrimidine zur bekämpfung von schadpilzen
DE69507028D1 (de) Verfahren und zusammensetzungen zur kontrolle der reaktivität zwischen diagnostischen reagenzien und mikroorganismen
ATE258598T1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE501120T1 (de) Verfahren zur herstellung von isoindolderivaten
ATE333522T1 (de) Verfahren zur bestimmung von mehrere analyten
DE60331422D1 (de) Fluoreszierendes protein aus aequorea coerulescens und ihre verwendungen
DE602004017884D1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
FI924713A (fi) Foerfarande foer saollning av proteinpartner och anvaendning av dessa
BR0013075A (pt) Derivados de tetrazolinona
HUP0300154A2 (en) Method for the production of spirocyclic tetronic acid derivatives
ATE500505T1 (de) Enzymhemmungsimmunverfahren
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
DE602004026110D1 (de) Verfahren zur inhibierung der verfärbung von methylenbisanilinverbindungen
PL428082A1 (pl) Sposób syntezy pochodnych pirydyn-2-yl-winylopirydynylowych (PvP)